However, it also has numerous side effects, including hot flashes and sweating, nausea and vomiting, loss of appetite, weight gain, vaginal discharge, irregular menstruation, excessive fatigue, headache, vaginal dryness, itching in the area surrounding the vagina, and more serious side effects such as liver disease, blood clots, depression, vision problems, and uterine or endometrial cancer 16
Bimagrumab is a human monoclonal antibody drug, whose mechanism of action stimulates the growth of skeletal muscle by blocking the activin type II receptor (ActRII)
Action: Weight loss and glucose regulation | Category: GLP-1 receptor agonist Experimental dosage: 0.25 mg from weeks 1 to 4, 0.5 mg from weeks 5 to 8, 1 mg from weeks 9 to 12, 1.7 mg from weeks 13 to 16, 2.4 mg from weeks 17 (for the treatment of obesity)
During this period, stay hydrated and monitor for headache, nausea, or injection-site changes